BIXT
Price:
$0.0791
Market Cap:
$7.04M
Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was incorporated ...[Read more]
Industry
Biotechnology
IPO Date
2010-01-05
Stock Exchange
OTC
Ticker
BIXT
According to Bioxytran, Inc.’s latest financial reports and current stock price. The company's current ROE is 84.19%. This represents a change of 287.26% compared to the average of 21.74% of the last 4 quarters.
The mean historical ROE of Bioxytran, Inc. over the last ten years is 233.87%. The current 84.19% ROE has changed -64.00% with respect to the historical average. Over the past ten years (40 quarters), BIXT's ROE was at its highest in in the March 2024 quarter at 270.24%. The ROE was at its lowest in in the December 2016 quarter at -46.55%.
Average
233.87%
Median
145.04%
Minimum
-58.70%
Maximum
1.08%
Discovering the peaks and valleys of Bioxytran, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 98.33%
Maximum Annual ROE = 1.08%
Minimum Annual Increase = -324.12%
Minimum Annual ROE = -58.70%
| Year | ROE | Change |
|---|---|---|
| 2024 | 132.07% | -24.98% |
| 2023 | 176.06% | 93.07% |
| 2022 | 91.19% | -42.06% |
| 2021 | 157.39% | 18.61% |
| 2020 | 132.70% | -49.14% |
| 2019 | 260.92% | 98.33% |
| 2018 | 131.56% | -324.12% |
| 2017 | -58.70% | -124.48% |
| 2016 | 239.77% | -77.71% |
| 2015 | 1.08% | 76.88% |
The current ROE of Bioxytran, Inc. (BIXT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
133.11%
5-year avg
137.88%
10-year avg
233.87%
Bioxytran, Inc.’s ROE is greater than Glow Lifetech Corp. (-131.44%), less than Burzynski Research Institute, Inc. (2.59%), less than Theralink Technologies, Inc. (147.47%), less than Kane Biotech Inc. (211.08%), less than BioVaxys Technology Corp. (380.38%), less than Mosaic ImmunoEngineering Inc. (61.97%), less than BetterLife Pharma Inc. (17.44%), greater than ProText Mobility, Inc. (0%), greater than NanoSphere Health Sciences Inc. (-18.06%), less than MYND Life Sciences Inc. (35.68%),
| Company | ROE | Market cap |
|---|---|---|
| -131.44% | $7.21M | |
| 2.59% | $5.78M | |
| 147.47% | $615.15K | |
| 211.08% | $4.16M | |
| 380.38% | $4.54M | |
| 61.97% | $4.38M | |
| 17.44% | $8.85M | |
| 0% | $9.11M | |
| -18.06% | $42.13K | |
| 35.68% | $1.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioxytran, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bioxytran, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bioxytran, Inc.'s ROE?
How is the ROE calculated for Bioxytran, Inc. (BIXT)?
What is the highest ROE for Bioxytran, Inc. (BIXT)?
What is the 3-year average ROE for Bioxytran, Inc. (BIXT)?
What is the 5-year average ROE for Bioxytran, Inc. (BIXT)?
How does the current ROE for Bioxytran, Inc. (BIXT) compare to its historical average?